CELF2-AS1

Model summary

A soluble human scaffold that accumulates in nuclear bodies and the nucleolus, where it assembles inhibitory complexes that suppress cell migration and invasion. By leveraging multivalent protein-binding capacity, it dampens the activity of matrix metalloproteinases and restrains invasion-related gene programs. Its nuclear localization enables coordination of transcriptional and RNA-processing pathways that converge on reduced protease output and decreased motility, consistent with a role as a negative regulator of invasion.

Predicted Gene Ontology terms

1. 01

   I begin with the InterPro architecture.

   The sequence carries a single annotated module: GO:0005515 protein binding. The presence of only a generic protein-binding signature and no catalytic or transmembrane domains indicates a soluble adaptor/scaffold rather than an enzyme or transporter. Such architectures typically mediate selective macromolecular interactions through low-complexity or modular binding surfaces, which causally supports a primary molecular function of protein binding.

2. 02

   From this binding-centric core, I infer higher-order roles by mapping the biological processes that this architecture enables.

   The protein is described as a negative regulator of cell migration and invasion, and its ability to inhibit MMP2 and MMP9 activity aligns with GO:0030336 negative regulation of cell migration and GO:0010951 negative regulation of endopeptidase activity. A binding-driven scaffold can directly sequester or spatially organize metalloproteinase complexes, reducing pericellular matrix degradation and thereby suppressing motility programs. The same binding capacity plausibly extends to transcriptional and RNA-processing assemblies that tune invasion-related gene expression.

3. 03

   Cellular localization sharpens this picture.

   The protein concentrates in nuclear substructures—nuclear bodies and the nucleolus—consistent with GO:0016604 nuclear body and with a broader nuclear residence. Nuclear bodies serve as hubs for transcription, splicing, and RNA surveillance; nucleolar residency often reflects roles in ribosome biogenesis and stress-responsive sequestration. A soluble, binding-competent scaffold that accumulates in nuclear bodies can modulate the availability and assembly of protease-regulatory factors and invasion-metastasis transcripts. This nuclear enrichment causally explains how the protein exerts transcriptional and post-transcriptional control over pathways that ultimately restrain MMP2/MMP9 activity and cell migratory behavior.

4. 04

   Mechanistically, I hypothesize that the protein assembles inhibitory complexes that curb metalloproteinase function and invasion signaling.

   By concentrating in nuclear bodies, it likely recruits transcriptional repressors and RNA-processing factors to dampen expression and maturation of pro-migratory genes, while directly binding MMP2/MMP9 to limit their activity. This dual nuclear-cytoplasmic buffering predicts reduced extracellular proteolysis and suppressed invasion. Likely interaction partners include MMP zymogens and their endogenous inhibitors, nuclear body constituents (such as PML and SP100), and nucleolar organizers; together these assemblies provide a coherent route from binding-driven scaffolding to suppression of migration and invasion.